Biotech · Private company
Neurocrine UK Limited
Track this companyFree. Adds Neurocrine UK Limited to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Chronocort®Phase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- CortefPhase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- HydrocortisonePhase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Standard CarePhase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- standard glucocorticoid therapyPhase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Hydrocortisone Modified Release CapsulesPhase 2 · Endocrine DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaPHASE3 · COMPLETED · started May 24, 2022ClinicalTrials.gov NCT05063994 · fetched Nov 12, 2026
- Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement TherapyPHASE3 · WITHDRAWN · started Oct 4, 2018ClinicalTrials.gov NCT03532022 · fetched Nov 12, 2026
- A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAHPHASE3 · COMPLETED · started Aug 18, 2016ClinicalTrials.gov NCT03062280 · fetched Nov 12, 2026
- Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal HyperplasiaPHASE3 · COMPLETED · started Feb 22, 2016ClinicalTrials.gov NCT02716818 · fetched Nov 12, 2026
- Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAHPHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01735617 · fetched Nov 12, 2026
- Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal HyperplasiaPHASE1_PHASE2 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00519818 · fetched Nov 12, 2026